3-Phosphono-L-alanine as pyrophosphate mimic for DNA synthesis using HIV-1 reverse transcriptase

Area of Science:

• Biochemistry
• Organic Chemistry
• Molecular Biology

Background:

• HIV-1 reverse transcriptase is a key target for antiviral therapies.
• Developing efficient substrates for enzymatic DNA synthesis is crucial for molecular biology applications.
• Amino acid phosphoramidate analogues offer potential as deoxynucleotide mimics.

Purpose of the Study:

• To synthesize and evaluate sulf(on)ate and phosph(on)ate amino acid phosphoramidate analogues as potential substrates for HIV-1 reverse transcriptase.
• To investigate the performance of different leaving groups (taurine, L-cysteic acid, 3-phosphono-L-alanine, O-sulfonato-L-serine, O-phospho-L-serine) in enzymatic DNA synthesis.
• To identify optimal analogues for efficient nucleic acid synthesis.

Main Methods:

• Synthesis of novel sulf(on)ate and phosph(on)ate amino acid phosphoramidate analogues.
• Enzyme-catalyzed DNA synthesis using HIV-1 reverse transcriptase.
• Single nucleotide incorporation assays to evaluate substrate efficiency and kinetics.
• Analysis of incorporation efficiency based on nucleotide sequence and base pairing rules.

Main Results:

• The phosphonate analogue, 3-phosphono-L-alanine, demonstrated the best performance among the synthesized compounds.
• 3-phosphono-L-alanine effectively mimics the pyrophosphate moiety of deoxyadenosine triphosphate.
• Substrate 3-phosphono-L-Ala-dAMP achieved 95% conversion to a P + 1 strand in 60 min at 50 μM, with improved kinetics and reduced stalling compared to L-Asp-dAMP.
• Nucleotide incorporation efficiency was base-dependent, decreasing in the order A ≥ T = G > C.
• Incorporation consistently followed Watson-Crick base pairing rules.

Conclusions:

• 3-phosphono-L-alanine is a promising analogue for enzymatic nucleic acid synthesis.
• This analogue serves as an excellent mimic of the pyrophosphate group in deoxynucleotides.
• The developed analogues show potential for applications in molecular biology and antiviral drug development targeting HIV-1 reverse transcriptase.